Brook.ai Receives $28 Million Funding to Transform Remote Healthcare Delivery Across the U.S.

Brook.ai's Transformative Growth in Remote Care

Brook.ai is redefining the landscape of remote care in the United States by securing $28 million in Series B funding, spearheaded by UMass Memorial Health and Morningside. This strategic investment is aimed at bolstering Brook.ai's mission—integrating remote care into the healthcare system to ensure continuous patient support beyond traditional settings.

Dr. Eric Dickson, President and CEO of UMass Memorial Health, emphasizes the effectiveness of Brook's innovative model, highlighting significant improvements in patient health. One of the standout achievements includes a staggering 90% reduction in readmissions for congestive heart failure (CHF) and an 80% increase in hypertension control rates within just six weeks of utilizing the platform. Such outcomes underscore Brook's potential to reshape care delivery across various health systems.

The influx of $28 million comes at a crucial juncture for Brook.ai, as it witnesses a surge in demand for its services. The company's unique approach not only drives patient satisfaction but also cultivates strong engagement. An impressive retention rate of 82% and a Net Promoter Score of 66 places the company in a favorable position within the health tech landscape, reflecting its growing value to both patients and providers alike.

Oren Nissim, the CEO of Brook.ai, remarks on the distinct nature of their platform, which facilitates everyday use at home, resulting in superior health outcomes. As Brook.ai enters this new phase, the partnership with UMass Memorial and Morningside will expand the reach of its outcomes-driven model to more health systems at a time when accessible healthcare is crucial.

Stephen Bruso from Morningside also voiced support for Brook.ai's differentiated platform, which couples robust clinical outcomes with notable benefits for partner health systems. The investment from UMass Memorial and Morningside is aimed at enhancing Brook's commercial activities while further developing its clinical reach.

With the healthcare sector evolving toward patient-centered remote care, Brook.ai addresses several pressing challenges—including workforce shortages, the rise of chronic diseases, and soaring costs. Their solution allows health systems to swiftly implement remote care strategies without the complexities associated with infrastructure, staffing, and billing—a critical factor as the healthcare landscape continues to evolve.

Brook.ai's service model is designed for rapid deployment, with health systems capable of launching within 30 days and without the need for substantial capital investments. The Series B funding will primarily be allocated for expanding services tailored to additional patient populations, bolstering their product and engineering teams with a focus on safe AI development, enhancing product features for better engagement, and scaling operations to support growth.

As Brook.ai continues to lead the charge in remote patient care, it embodies a blueprint for the future—where accessible, continuous care is not just a goal but a reality for all patients. For further details about Brook's innovative remote care platform, visit brook.ai.